Affordable Access

Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients.

Authors
  • Gross, Evan
  • Rothstein, Marcos
  • Dombek, Susan
  • Juknis, Henrikas Irmantas
Type
Published Article
Journal
American Journal of Kidney Diseases
Publisher
Elsevier
Publication Date
Jul 01, 2005
Volume
46
Issue
1
Pages
94–101
Identifiers
PMID: 15983962
Source
Medline
License
Unknown

Abstract

When administered for 2 weeks, spironolactone, 50 mg twice daily, reduced predialysis systolic blood pressure, but did not produce hyperkalemia in oligo-anuric hemodialysis patients.

Report this publication

Statistics

Seen <100 times